Cite
PAM50 subtyping and ROR score add long-term prognostic information in premenopausal breast cancer patients
MLA
Lundgren, Christine, et al. PAM50 Subtyping and ROR Score Add Long-Term Prognostic Information in Premenopausal Breast Cancer Patients. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1348926493&authtype=sso&custid=ns315887.
APA
Lundgren, C., Bendahl, P.-O., Church, S. E., Ekholm, M., Fernö, M., Forsare, C., Krüger, U., Nordenskjöld, B., Stål, O., & Rydén, L. (2022). PAM50 subtyping and ROR score add long-term prognostic information in premenopausal breast cancer patients.
Chicago
Lundgren, Christine, Pär-Ola Bendahl, Sarah E. Church, Maria Ekholm, Mårten Fernö, Carina Forsare, Ute Krüger, Bo Nordenskjöld, Olle Stål, and Lisa Rydén. 2022. “PAM50 Subtyping and ROR Score Add Long-Term Prognostic Information in Premenopausal Breast Cancer Patients.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1348926493&authtype=sso&custid=ns315887.